Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications.
Kumar P, Uppal M, Xiao W, Dogan A, Roshal M, Gao Q, Aypar U, Zhang Y, Arcila ME, Moung C, Yao J, Nafa K, Yu W, Syed MH, Park J, Kumar A, Ho C. Kumar P, et al. Among authors: aypar u. Leuk Lymphoma. 2020 Feb;61(2):460-464. doi: 10.1080/10428194.2019.1675876. Epub 2019 Oct 15. Leuk Lymphoma. 2020. PMID: 31612754 Free PMC article. No abstract available.
Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition.
Yao J, Xu L, Aypar U, Meyerson HJ, Londono D, Gao Q, Baik J, Dietz J, Benayed R, Sigler A, Yabe M, Dogan A, Arcila ME, Roshal M, Zhang Y, Mauro MJ, Xiao W. Yao J, et al. Among authors: aypar u. Haematologica. 2021 Feb 1;106(2):614-618. doi: 10.3324/haematol.2020.249649. Haematologica. 2021. PMID: 32299902 Free PMC article. No abstract available.
P2RY8-CRLF2Fusion-Positive Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Response to Novel Therapy.
Aypar U, Taylor J, Garcia JS, Momeni-Boroujeni A, Gao Q, Baik J, Londono D, Benayed R, Sigler A, Haddadin M, Penson AV, Arcila ME, Mullaney K, Sukhadia P, Quesada AE, Roshal M, Cullen N, Lako A, Rodig SJ, Goldberg AD, Zhang Y, Xiao W, Ho C. Aypar U, et al. JCO Precis Oncol. 2020;4:152-160. doi: 10.1200/PO.19.00294. Epub 2020 Mar 5. JCO Precis Oncol. 2020. PMID: 32395681 Free PMC article. No abstract available.
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.
Taylor J, Donoghue MT, Ho C, Petrova-Drus K, Al-Ahmadie HA, Funt SA, Zhang Y, Aypar U, Rao P, Chavan SS, Haddadin M, Tamari R, Giralt S, Tallman MS, Rampal RK, Baez P, Kappagantula R, Kosuri S, Dogan A, Tickoo SK, Reuter VE, Bosl GJ, Iacobuzio-Donahue CA, Solit DB, Taylor BS, Feldman DR, Abdel-Wahab O. Taylor J, et al. Among authors: aypar u. J Clin Invest. 2020 Dec 1;130(12):6668-6676. doi: 10.1172/JCI139682. J Clin Invest. 2020. PMID: 32897884 Free PMC article.
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.
Johnson WT, Ganesan N, Epstein-Peterson ZD, Moskowitz AJ, Stuver RN, Maccaro CR, Galasso N, Chang T, Khan N, Aypar U, Lewis NE, Zelenetz AD, Palomba ML, Matasar MJ, Noy A, Hamilton AM, Hamlin P, Caron PC, Straus DJ, Intlekofer AM, Lee Batlevi C, Kumar A, Owens CN, Sauter CS, Falchi L, Lue JK, Vardhana SA, Salles G, Dogan A, Schultz ND, Arcila ME, Horwitz SM. Johnson WT, et al. Among authors: aypar u. Blood Adv. 2023 Sep 12;7(17):5172-5186. doi: 10.1182/bloodadvances.2023009953. Blood Adv. 2023. PMID: 37078708 Free PMC article.
166 results